Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2022 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Announces Publication in Tissue Barriers Providing Additional Insight into Company’s Proprietary Technology Platform

Publication describes critical interactions between cholix-based transport domain and endogenous intracellular trafficking pathways used by Company’s proprietary biologic product candidates to cross...
April 06, 2022 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Appoints Charlene Banard to its Board of Directors

SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of...
March 14, 2022 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Appoints Industry Veteran Carolyn Finkle as Senior Vice President, Head of Regulatory Affairs

Company continues to strengthen key functions and corporate leadership Company on track to announce top-line data from four ongoing oral AMT-101 Phase 2 trials in 2022 SOUTH SAN FRANCISCO, Calif.,...
February 24, 2022 16:01 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Four top-line data readouts expected in 2022 from ongoing oral AMT-101 Phase 2 trials, as follows FILLMORE monotherapy trial for patients with chronic pouchitis followed by MARKET combination trial...
February 10, 2022 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
January 27, 2022 16:30 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Announces Board Appointments

John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair Helen S. Kim Named Lead Independent Director SOUTH SAN FRANCISCO, Calif.,...
November 15, 2021 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport to Present at Virtual Jefferies London Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Bittoo Kanwar,...
November 10, 2021 16:01 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Top-line data readout for oral AMT-101 Phase 2 MARKET combination trial with anti-TNFα in ulcerative colitis (UC) expected in H1 2022 Top-line data readouts from three additional oral AMT-101 Phase 2...
October 11, 2021 16:01 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport to Host Virtual Research & Development Day on October 15, 2021

Management to highlight novel oral biologics technology platform, clinical programs and research activities Feature distinguished IBD and rheumatology key opinion leaders Provide update on the four...
September 17, 2021 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Announces Upcoming Investor Events in September and October

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the company...